Data Collection Evaluation Question Indicators Performance Measure Data Collection Data Collection Sources Frequency What are the facilitating Mammograms Percentage of NBCCEDP funded Screening Data Monthly, Quarterly, factors and barriers to Provided to Women 50 mammograms provided to women 50 Patient/Provider Annually screening site Years of Age and Pap years of age and older and pap smears Experience performance? Smears Provided to provided to women 21-64 years of age Semi Structured How will barriers be Women 21-64 Years of (goal: >= 75%) Interviews, Site reduced? Age Observation To what extent are Abnormal Screening Percentage of abnormal Pap tests with Screening Data, Monthly, Quarterly, women screened at each Results with Complete complete follow-up (goal: >= Site Observation Annually site retained through the Follow-Up 90%) completion of their plan of care? Abnormal Screening Percentage of abnormal breast screenings Screening Data Monthly, Quarterly, Results; Time from with complete follow-up Annually Screening to Diagnosis (goal: >= 90%) > 90 Days Abnormal Screening Percentage of abnormal breast screenings Site Observation Monthly, Quarterly, Results with Complete where the time between the Annually Follow-Up screening/referral and final diagnosis was > 60 days (goal: <= 25%) Abnormal Screening Percentage of final diagnosis of breast Screening Data Monthly, Quarterly, Results; Time from cancer where the time between the date of Annually Screening to Diagnosis final diagnosis and the date of treatment > 60 Days initiation is > 60 days (goal: <= 20%)
Data Collection Evaluation Question Indicators Performance Measure Data Collection Sources Data Collection Frequency What are the facilitating factors and barriers to screening site performance? How will barriers be reduced? Mammograms Provided to Women 50 Years of Age and Pap Smears Provided to Women 21-64 Years of Age Percentage of NBCCEDP funded mammograms provided to women 50 years of age and older and pap smears provided to women 21-64 years of age (goal: >= 75%) Screening Data Patient/Provider Experience Semi Structured Interviews, Site Observation Monthly, Quarterly, Annually To what extent are women screened at each site retained through the completion of their plan of care? Abnormal Screening Results with Complete Follow-Up Percentage of abnormal Pap tests with complete follow-up (goal: >= 90%) Screening Data, Site Observation Monthly, Quarterly, Annually Abnormal Screening Results; Time from Screening to Diagnosis > 90 Days Percentage of abnormal breast screenings with complete follow-up (goal: >= 90%) Screening Data Monthly, Quarterly, Annually Abnormal Screening Results with Complete Follow-Up Percentage of abnormal breast screenings where the time between the screening/referral and final diagnosis was > 60 days (goal: <= 25%) Site Observation Monthly, Quarterly, Annually Abnormal Screening Results; Time from Screening to Diagnosis > 60 Days Percentage of final diagnosis of breast cancer where the time between the date of final diagnosis and the date of treatment initiation is > 60 days (goal: <= 20%) Screening Data Monthly, Quarterly, Annually
072015%20GBCCP%20Evaluation%20Plan_%20Final.docx